Resistant mutants of Staphylococcus aureus with ofloxacin in comparison with ciprofloxacin

被引：0
|
作者：
Rio, Y [1 ]
Jurin, F [1 ]
Didion, J [1 ]
机构：
[1] CHR Metz Thionville, Bacteriol Lab, Hop ND Bon Secours, F-57000 Metz, France
来源：
DRUGS | 1999年 / 58卷 / Suppl 2期
关键词：
D O I：
10.2165/00003495-199958002-00031
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：130 / 131
页数：2
相关论文
共 50 条
  • [31] An in vitro resistance study of levofloxacin, ciprofloxacin, and ofloxacin using keratitis isolates of Staphylococcus aureus and Pseudomonas aeruginosa
    Kowalski, RP
    Pandya, AN
    Karenchak, LM
    Romanowski, EG
    Husted, RC
    Ritterband, BC
    Shah, MK
    Gordon, YJ
    OPHTHALMOLOGY, 2001, 108 (10) : 1826 - 1829
  • [32] Effectiveness of topical taurolidine versus ciprofloxacin, ofloxacin, and fortified cefazolin in a rabbit Staphylococcus aureus keratitis model
    Oguz, H
    Ozbilge, H
    Oguz, E
    Gurkan, T
    CURRENT EYE RESEARCH, 2005, 30 (03) : 155 - 161
  • [33] Comparison of the effect of ciprofloxacin and Tazocin® on the incidence of meticillin-resistant Staphylococcus aureus (MRSA) in an Intensive Care Unit
    Aldeyab, Mamoon A.
    Hughes, Carmel M.
    Kearney, Mary P.
    Scott, Michael G.
    McDowell, David A.
    Hanley, Joanne
    McMahon, M. Ann S.
    Elshibly, Salah M.
    Bailie, Ronald
    McElnay, James C.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2008, 32 (06) : 499 - 504
  • [34] In Vitro Susceptibility of Ciprofloxacin-Resistant Methicillin-Resistant Staphylococcus aureus to Ototopical Therapy
    Walker, David D.
    David, Michael Z.
    Catalano, Dominic
    Daum, Robert
    Gluth, Michael B.
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2018, 158 (05) : 923 - 929
  • [35] BETA-LACTAM-SPECIFIC RESISTANT MUTANTS OF STAPHYLOCOCCUS-AUREUS
    TONIN, E
    TOMASZ, A
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 30 (04) : 577 - 583
  • [36] Characterization of sparfloxacin-resistant mutants of Staphylococcus aureus obtained in vitro
    Ruiz, J
    Sierra, JM
    De Anta, MTJ
    Vila, J
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2001, 18 (02) : 107 - 112
  • [37] CIPROFLOXACIN THERAPY FOR METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS INFECTIONS OR COLONIZATIONS
    SMITH, SM
    ENG, RHK
    TECSONTUMANG, F
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (02) : 181 - 184
  • [38] Effectiveness of ciprofloxacin and ofloxacin in a prophylaxis model of Staphylococcus keratitis
    Dajcs, JJ
    Moreau, JM
    Thibodeaux, BA
    Traidej, M
    Austin, MS
    Marquart, ME
    Stroman, DW
    O'Callaghan, RJ
    CORNEA, 2001, 20 (08) : 878 - 880
  • [39] DIFFERING ACTIVITIES OF QUINOLONES AGAINST CIPROFLOXACIN-SUSCEPTIBLE AND CIPROFLOXACIN-RESISTANT, METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS
    MAPLE, PAC
    HAMILTONMILLER, JMT
    BRUMFITT, W
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (02) : 345 - 350
  • [40] CIPROFLOXACIN STAPHYLOCOCCUS-AUREUS RESISTANCE
    PANE, FJ
    RINGER, L
    CHILD, JA
    MILLER, DM
    DICP-THE ANNALS OF PHARMACOTHERAPY, 1990, 24 (04): : 439 - 439
12345